Journal article
International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction
Abstract
BACKGROUND: International geographic differences in outcomes may exist for clinical trials of heart failure and reduced ejection fraction (HF-REF), but there are few data for those with preserved ejection fraction (HF-PEF).
METHODS AND RESULTS: We analyzed outcomes by international geographic region in the Irbesartan in Heart Failure with Preserved systolic function trial (I-Preserve), the Candesartan in Heart failure Assessment of Reduction in …
Authors
Kristensen SL; Køber L; Jhund PS; Solomon SD; Kjekshus J; McKelvie RS; Zile MR; Granger CB; Wikstrand J; Komajda M
Journal
Circulation, Vol. 131, No. 1, pp. 43–53
Publisher
Wolters Kluwer
Publication Date
January 6, 2015
DOI
10.1161/circulationaha.114.012284
ISSN
0009-7322
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAged, 80 and overAngiotensin II Type 1 Receptor BlockersBenzimidazolesBiphenyl CompoundsCanadaEuropeFemaleFluorobenzenesGeographyHeart FailureHospitalizationHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIrbesartanMaleMiddle AgedPyrimidinesRisk FactorsRosuvastatin CalciumRussiaStroke VolumeSulfonamidesTetrazolesTreatment OutcomeUnited States